RenovoRx, Inc. (RNXT)
1.67
+0.19
(+12.84%)
USD |
NASDAQ |
Aug 28, 16:00
1.70
+0.03
(+1.80%)
After-Hours: 20:00
RenovoRx Price : 1.67 for Aug. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | 1.48 | 1.679 | 1.470 | 1.67 | 1.055M |
| Aug 27, 2026 | 1.47 | 1.55 | 1.43 | 1.48 | 428932.0 |
| Aug 26, 2026 | 1.41 | 1.55 | 1.385 | 1.49 | 763831.0 |
| Aug 25, 2026 | 1.30 | 1.56 | 1.27 | 1.42 | 1.345M |
| Aug 24, 2026 | 1.33 | 1.358 | 1.24 | 1.25 | 264048.0 |
| Aug 21, 2026 | 1.30 | 1.325 | 1.25 | 1.32 | 233271.0 |
| Aug 20, 2026 | 1.29 | 1.35 | 1.23 | 1.32 | 381177.0 |
| Aug 19, 2026 | 1.17 | 1.337 | 1.15 | 1.315 | 582345.0 |
| Aug 18, 2026 | 1.21 | 1.269 | 1.12 | 1.17 | 498972.0 |
| Aug 17, 2026 | 1.415 | 1.505 | 1.180 | 1.20 | 1.223M |
| Aug 14, 2026 | 1.27 | 1.45 | 1.26 | 1.40 | 1.007M |
| Aug 13, 2026 | 1.12 | 1.30 | 1.12 | 1.26 | 993808.0 |
| Aug 12, 2026 | 1.14 | 1.16 | 1.10 | 1.12 | 477074.0 |
| Aug 11, 2026 | 1.16 | 1.20 | 1.12 | 1.15 | 361521.0 |
| Aug 10, 2026 | 1.14 | 1.16 | 1.09 | 1.16 | 317700.0 |
| Aug 07, 2026 | 1.17 | 1.20 | 1.10 | 1.12 | 317826.0 |
| Aug 06, 2026 | 1.07 | 1.18 | 1.07 | 1.15 | 693597.0 |
| Aug 05, 2026 | 1.06 | 1.100 | 1.04 | 1.06 | 316722.0 |
| Aug 04, 2026 | 0.9811 | 1.06 | 0.98 | 1.04 | 401845.0 |
| Aug 03, 2026 | 0.9653 | 1.100 | 0.95 | 1.06 | 703843.0 |
| Jul 31, 2026 | 0.95 | 0.97 | 0.9234 | 0.9583 | 244992.0 |
| Jul 30, 2026 | 0.91 | 0.9499 | 0.91 | 0.9412 | 113573.0 |
| Jul 29, 2026 | 0.91 | 0.9296 | 0.8866 | 0.8981 | 127619.0 |
| Jul 28, 2026 | 0.9325 | 0.9699 | 0.88 | 0.9073 | 219741.0 |
| Jul 27, 2026 | 0.90 | 0.98 | 0.871 | 0.9651 | 868805.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Enanta Pharmaceuticals, Inc. | 13.60 |
| Travere Therapeutics, Inc. | 65.67 |
| REGENXBIO, Inc. | 9.66 |
| Krystal Biotech, Inc. | 351.46 |
| ACADIA Pharmaceuticals, Inc. | 29.11 |
Price Related Metrics
| PS Ratio | 33.51 |
| Price to Book Value | 8.392 |
| Earnings Yield | -18.80% |
| Market Cap | 75.35M |